Commonwealth Equity Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.13M Sell
32,565
-4,279
-12% -$280K ﹤0.01% 1931
2025
Q1
$2.6M Sell
36,844
-3,404
-8% -$240K ﹤0.01% 1722
2024
Q4
$2.65M Buy
40,248
+2,106
+6% +$138K ﹤0.01% 1677
2024
Q3
$2.69M Sell
38,142
-30
-0.1% -$2.12K ﹤0.01% 1616
2024
Q2
$2.53M Buy
38,172
+2,589
+7% +$172K ﹤0.01% 1632
2024
Q1
$2.42M Sell
35,583
-1,476
-4% -$100K ﹤0.01% 1650
2023
Q4
$2.29M Sell
37,059
-2,433
-6% -$150K ﹤0.01% 1605
2023
Q3
$2.33M Sell
39,492
-1,827
-4% -$108K ﹤0.01% 1509
2023
Q2
$2.47M Buy
41,319
+474
+1% +$28.3K 0.01% 1488
2023
Q1
$2.39K Buy
40,845
+849
+2% +$50 0.01% 1453
2022
Q4
$2.48M Buy
39,996
+3,471
+10% +$215K 0.01% 1363
2022
Q3
$2.06M Sell
36,525
-1,311
-3% -$74.1K 0.01% 1398
2022
Q2
$2.42M Sell
37,836
-1,782
-4% -$114K 0.01% 1314
2022
Q1
$2.57M Sell
39,618
-1,020
-3% -$66K 0.01% 1342
2021
Q4
$2.7M Sell
40,638
-5,151
-11% -$343K 0.01% 1293
2021
Q3
$2.8M Sell
45,789
-156
-0.3% -$9.52K 0.01% 1214
2021
Q2
$2.84M Buy
45,945
+777
+2% +$48.1K 0.01% 1196
2021
Q1
$2.67M Sell
45,168
-114
-0.3% -$6.75K 0.01% 1133
2020
Q4
$2.71M Buy
45,282
+21
+0% +$1.26K 0.01% 1048
2020
Q3
$2.47M Buy
45,261
+819
+2% +$44.6K 0.01% 985
2020
Q2
$2.28M Buy
44,442
+978
+2% +$50.2K 0.01% 972
2020
Q1
$1.95M Sell
43,464
-2,391
-5% -$107K 0.01% 913
2019
Q4
$2.45M Sell
45,855
-1,740
-4% -$92.9K 0.01% 926
2019
Q3
$2.22M Sell
47,595
-3,612
-7% -$168K 0.01% 925
2019
Q2
$2.57M Sell
51,207
-16,575
-24% -$833K 0.01% 844
2019
Q1
$3.48M Buy
67,782
+4,281
+7% +$220K 0.02% 679
2018
Q4
$2.98M Buy
63,501
+5,466
+9% +$256K 0.02% 659
2018
Q3
$3.25M Sell
58,035
-660
-1% -$36.9K 0.02% 685
2018
Q2
$2.96M Sell
58,695
-4,035
-6% -$204K 0.02% 707
2018
Q1
$3.09M Sell
62,730
-5,532
-8% -$272K 0.02% 656
2017
Q4
$3.51M Buy
68,262
+1,503
+2% +$77.4K 0.02% 593
2017
Q3
$3.48M Sell
66,759
-1,140
-2% -$59.4K 0.02% 565
2017
Q2
$3.51M Sell
67,899
-759
-1% -$39.2K 0.02% 542
2017
Q1
$3.45M Buy
68,658
+3,054
+5% +$154K 0.02% 541
2016
Q4
$3.09M Buy
65,604
+264
+0.4% +$12.4K 0.02% 550
2016
Q3
$3.26M Sell
65,340
-3,117
-5% -$155K 0.03% 499
2016
Q2
$3.3M Sell
68,457
-12,933
-16% -$622K 0.03% 480
2016
Q1
$3.72M Sell
81,390
-2,655
-3% -$121K 0.03% 431
2015
Q4
$4.53M Sell
84,045
-3,945
-4% -$213K 0.04% 357
2015
Q3
$4.34M Buy
87,990
+3,231
+4% +$159K 0.05% 337
2015
Q2
$4.94M Buy
84,759
+3,117
+4% +$182K 0.05% 336
2015
Q1
$4.69M Buy
81,642
+3,318
+4% +$191K 0.05% 334
2014
Q4
$3.95M Buy
78,324
+4,500
+6% +$227K 0.04% 360
2014
Q3
$3.45M Buy
73,824
+9,597
+15% +$449K 0.04% 367
2014
Q2
$2.89M Buy
64,227
+2,442
+4% +$110K 0.04% 427
2014
Q1
$2.61M Buy
61,785
+4,806
+8% +$203K 0.04% 424
2013
Q4
$2.24M Buy
56,979
+5,976
+12% +$235K 0.03% 460
2013
Q3
$1.81M Sell
51,003
-1,926
-4% -$68.3K 0.03% 483
2013
Q2
$1.76M Buy
+52,929
New +$1.76M 0.03% 457